Trial Profile
Phase II study of GW786034 [pazopanib] in patients with malignant pleural mesothelioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2021
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 21 Dec 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.